Inhibitory effect of αS1- and αS2-casein hydrolysates on angiotensin I-converting enzyme in human endothelial cells in vitro, rat aortic tissue ex vivo, and renovascular hypertensive rats in vivo

Journal of Dairy Science

Volumn 93, Issue 7, 2010, Pages 2906-2921

  Rousseau Ralliard, D ^a   Goirand, F ^a   Tardivel, S ^a,b   Lucas, A ^a,b   Algaron, F ^c   Molle D ^d   Robert, V ^a   Auchere D ^a   Boudier, J F ^e   Gaillard, J L ^f   Monnet, V ^c   Tauzin, J ^e   Grynberg, A ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c CEMAGREF   (France)

^d AGROCAMPUS OUEST   (France)

^e INGREDIA   (France)

^f UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Angiotensin converting enzyme; Blood pressure; Milk trypsin hydrolysate

Indexed keywords

CASEIN; CASEIN HYDROLYSATE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL; AORTA; ARTICLE; BLOOD PRESSURE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; MALE; METABOLISM; RAT; VASOCONSTRICTION; WISTAR RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; AORTA; BLOOD PRESSURE; CASEINS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; VASOCONSTRICTION;

RATTUS;

EID: 77953911229     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2010-3060     Document Type: Article

References (59)

1. Balyasnikova I.V., Danilov S.M., Muzykantov V.R., Fisher A.B. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro Cell. Dev. Biol. Anim. 1998, 34:545-554.
2. Bechgaard E., Bagger M., Larsen R., Nielsen H.W. High-performance liquid chromatographic analysis of Peptide T in rabbit plasma with on-line column enrichment. J. Chromatogr. B Biomed. Sci. Appl. 1997, 693:237-240.
3. Bennett M.A., Watt P.A., Thurston H. Impaired endothelium-dependent relaxation in two-kidney, one clip Goldblatt hypertension: Effect of vasoconstrictor prostanoids. J. Hypertens. Suppl. 1993, 11:S134-S135.
4. Bicket D.P. Using ACE inhibitors appropriately. Am. Fam. Physician 2002, 66:461-468.
5. Cadée J.A., Chang C.Y., Chen C.W., Huang C.N., Chen S.L., Wang C.K. Bovine casein hydrolysate (c12 Peptide) reduces blood pressure in prehypertensive subjects. Am. J. Hypertens. 2007, 20:1-5.
6. Cambridge D., Whiting M.V. Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: Responses to changes in cardiac loading and heart rate. Cardiovasc. Res. 1986, 20:444-450.
7. Campbell D.J., Duncan A.M., Kladis A., Harrap S.B. Converting enzyme inhibition and its withdrawal in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 1995, 26:426-436.
8. Centeno J.M., Burguete M.C., Castello-Ruiz M., Enrique M., Valles S., Salom J.B., Torregrosa G., Marcos J.F., Alborch E., Manzanares P. Lactoferricin-related peptides with inhibitory effects on ACE-dependent vasoconstriction. J. Agric. Food Chem. 2006, 54:5323-5329.
9. Chabance B., Marteau P., Rambaud J.C., Migliore-Samour D., Boynard M., Perrotin P., Guillet R., Jolles P., Fiat A.M. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998, 80:155-165.
10. Cushman D.W., Cheung H.S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20:1637-1648.
11. Duarte C.G., Zhang J., Ellis S. Review of studies establishing the aging male spontaneously hypertensive rat as a detector and quantifier of the kidney toxicity of radiocontrast media and other chemicals. Invest. Radiol. 2001, 36:56-63.
12. Edmunds M.E., Russell G.I., Swales J.D. Vascular capacitance and reversal of 2-kidney, 1-clip hypertension in rats. Am. J. Physiol. 1989, 256:H502-H507.
13. Endo T., Miyagi M., Ujiie A. Simultaneous determination of glycyl-L-histidyl-L-lysine and its metabolite, L-histidyl-L-lysine, in rat plasma by high-performance liquid chromatography with post-column derivatization. J. Chromatogr. B Biomed. Sci. Appl. 1997, 692:37-42.
14. Fosset S., Fromentin G., Gietzen D.W., Dubarry M., Huneau J.F., Antoine J.M., Lang V., Mathieu-Casseron F., Tome D. Peptide fragments released from Phe-caseinomacropeptide in vivo in the rat. Peptides 2002, 23:1773-1781.
15. Fuglsang A., Nilsson D., Nyborg N.C. Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo. J. Enzyme Inhib. Med. Chem. 2003, 18:407-412.
16. Fuglsang A., Nilsson D., Nyborg N.C. Using spectrophotometry to determine in vitro turnover rates of peptides in plasma. J. Biochem. Biophys. Methods 2004, 58:139-151.
17. Gagnaire V., Pierre A., Molle D., Leonil J. Phosphopeptides interacting with colloidal calcium phosphate isolated by tryptic hydrolysis of bovine casein micelles. J. Dairy Res. 1996, 63:405-422.
18. Gardner M.L. Gastrointestinal absorption of intact proteins. Annu. Rev. Nutr. 1988, 8:329-350.
19. Geerlings A., Villar I.C., Hidalgo Z.F., Sanchez M., Vera R., Zafra G.A., Boza J., Duarte J. Identification and characterization of novel angiotensin-converting enzyme inhibitors obtained from goat milk. J. Dairy Sci. 2006, 89:3326-3335.
20. Goldblatt H. Experimental renal hypertension. Am. J. Med. 1948, 4:100-119.
21. Grynberg A. Hypertension prevention: from nutrients to (fortified) foods to dietary patterns. Focus on fatty acids. J. Hum. Hypertens. 2005, 19(Suppl 3):S25-S33.
22. Guédon J., Lucsko M., Cuche J.L., Chaignon M. Renovascular hypertension and beta blockers. Theoretical and practical implications. Arch. Mal. Coeur Vaiss. 1979, 72(Spec no):9-15. (in French).
23. Guesdon B., Messaoudi M., Lefranc-Millot C., Fromentin G., Tome D., Even P.C. A tryptic hydrolysate from bovine milk alphaS1-casein improves sleep in rats subjected to chronic mild stress. Peptides 2006, 27:1476-1482.
24. Hirota T., Ohki K., Kawagishi R., Kajimoto Y., Mizuno S., Nakamura Y., Kitakaze M. Casein hydrolysate containing the antihypertensive tripeptides Val-Pro-Pro and Ile-Pro-Pro improves vascular endothelial function independent of blood pressure-lowering effects: contribution of the inhibitory action of angiotensin-converting enzyme. Hypertens. Res. 2007, 30:489-496.
25. Huth P.J., DiRienzo D.B., Miller G.D. Major scientific advances with dairy foods in nutrition and health. J. Dairy Sci. 2006, 89:1207-1221.
26. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
27. Korhonen H., Pihlanto A. Technological options for the production of health-promoting proteins and peptides derived from milk and colostrum. Curr. Pharm. Des. 2007, 13:829-843.
28. Korner P.I. Cardiovascular hypertrophy and hypertension: Causes and consequences. Blood Press. Suppl. 1995, 2:6-16.
29. Lecouvey M., Frochot C., Miclo L., Orlewski P., Driou A., Linden G., Gaillard J.L., Marraud M., Cung M.T., Vanderesse R. Two-dimensional 1H-NMR and CD structural analysis in a micellar medium of a bovine alphaS1-casein fragment having benzodiazepine-like properties. Eur. J. Biochem. 1997, 248:872-878.
30. Li G.H., Le G.W., Shi Y.H., Shrestha S. Angiotensin I-converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects. Nutr. Res. 2004, 24:469-486.
31. London G.M., Guerin A.P., Pannier B., Marchais S.J., Safar M.E. Large artery structure and function in hypertension and end-stage renal disease. J. Hypertens. 1998, 16:1931-1938.
32. Maeno M., Yamamoto N., Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 1996, 79:1316-1321.
33. Maruyama S., Mitachi H., Awaya J., Kurono M., Tomizuka N., Suzuki H. Angiotensin I-converting enzyme inhibitory activity of the C-terminal hexapeptide of αS1-casein. Agric. Biol. Chem. 1987, 51:2257-2261.
34. Maruyama S., Suzuki H. A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein. Agric. Biol. Chem. 1982, 46:1393-1394.
35. Masuda O., Nakamura Y., Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 1996, 126:3063-3068.
36. Matsufuji H., Matsui T., Ohshige S., Kawasaki T., Osajima K., Osajima Y. Antihypertensive effects of angiotensin fragments in SHR. Biosci. Biotechnol. Biochem. 1995, 59:1398-1401.
37. Meisel H., Fitzgerald R.J. Biofunctional peptides from milk proteins: mineral binding and cytomodulatory effects. Curr. Pharm. Des. 2003, 9:1289-1295.
38. Messaoudi M., Lefranc-Millot C., Desor D., Demagny B., Bourdon L. Effects of a tryptic hydrolysate from bovine milk alphaS1-casein on hemodynamic responses in healthy human volunteers facing successive mental and physical stress situations. Eur. J. Nutr. 2005, 44:128-132.
39. Michel J.B., Dussaule J.C., Choudat L., Auzan C., Nochy D., Corvol P., Menard J. Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats. Kidney Int. 1986, 29:1011-1020.
40. Mizuno S., Matsuura K., Gotou T., Nishimura S., Kajimoto O., Yabune M., Kajimoto Y., Yamamoto N. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. Br. J. Nutr. 2005, 94:84-91.
41. Mizushima S., Ohshige K., Watanabe J., Kimura M., Kadowaki T., Nakamura Y., Tochikubo O., Ueshima H. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am. J. Hypertens. 2004, 17:701-706.
42. Mullally M.M., Meisel H., FitzGerald R.J. Synthetic peptides corresponding from alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biol. Chem. Hoppe Seyler 1996, 377:259-260.
43. Nabhan M.A., Girardet J.M., Campagna S., Gaillard J.L., Le Roux Y. Isolation and characterization of copolymers of beta-lactoglobulin, alpha-lactalbumin, kappa-casein, and alphas1-casein generated by pressurization and thermal treatment of raw milk. J. Dairy Sci. 2004, 87:3614-3622.
44. Nakamura Y., Yamamoto N., Sakai K., Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 1995, 78:1253-1257.
45. Nurminen M.L., Sipola M., Kaarto H., Pihlanto-Leppala A., Piilola K., Korpela R., Tossavainen O., Korhonen H., Vapaatalo H. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci. 2000, 66:1535-1543.
46. Pihlanto-Leppala A., Rokkat T., Korhonen H. Angiotensin I converting enzyme inhibitory peptides derived from bovine milk proteins. Int. Dairy J. 1998, 8:325-331.
47. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993, 123:1939-1951.
48. Robbez Masson V., Lucas A., Gueugneau A.M., Macaire J.P., Paul J.L., Grynberg A., Rousseau D. Long-chain (n-3) polyunsaturated fatty acids prevent metabolic and vascular disorders in fructose-fed rats. J. Nutr. 2008, 138:1915-1922.
49. Rousseau D., Helies-Toussaint C., Moreau D., Raederstorff D., Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and cardiac impairments in a hyperinsulinemia rat model in vivo. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1294-H1302.
50. Rousseau D., Helies-Toussaint C., Raederstorff D., Moreau D., Grynberg A. Dietary n-3 polyunsaturated fatty acids affect the development of renovascular hypertension in rats. Mol. Cell Biochem. 2001, 225:109-119.
51. Sano J., Ohki K., Higuchi T., Aihara K., Mizuno S., Kajimoto O., Nakagawa S., Kajimoto Y., Nakamura Y. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. J. Med. Food 2005, 8:423-430.
52. Sekiya S., Kobayashi Y., Kita E., Imamura Y., Toyama Y. Antihypertensive effects of tryptic hydrolysate of casein on normotensive and hypertensive volunteers. J. Jpn. Soc. Nutr. Food Sci. 1992, 45:513-517. (in Japanese).
53. Seppo L., Jauhiainen T., Poussa T., Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 2003, 77:326-330.
54. Skeggs L.T., Kahn J.R., Shumway N.P. The preparation and function of the hypertensin-converting enzyme. J. Exp. Med. 1956, 103:295-299.
55. Tauzin J., Miclo L., Gaillard J.L. Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein. FEBS Lett. 2002, 531:369-374.
56. Todorova V.K. Proteolytic enzymes secreted by larval stage of the parasitic nematode Trichinella spiralis. Folia Parasitol. (Praha) 2000, 47:141-145.
57. Vermeirssen V., Van Camp J., Verstraete W. Bioavailability of angiotensin I converting enzyme inhibitory peptides. Br. J. Nutr. 2004, 92:357-366.
58. Volland H., Pradelles P., Ronco P., Azizi M., Simon D., Creminon C., Grassi J. A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma. J. Immunol. Methods 1999, 228:37-47.
59. Yamamoto N. Antihypertensive peptides derived from food proteins. Biopolymers 1997, 43:129-134.